Early Quantitative Evaluation of a Tumor Vasculature Disruptive Agent AVE8062 Using Dynamic Contrast-Enhanced Ultrasonography-Reference-Cited by-同舟云学术

Early Quantitative Evaluation of a Tumor Vasculature Disruptive Agent AVE8062 Using Dynamic Contrast-Enhanced Ultrasonography

Published:2008-02 Issue:2 Volume:43 Page:100-111
ISSN:0020-9996
Container-title:Investigative Radiology
language:en
Short-container-title:Investigative Radiology

Author:

Lavisse Sonia,Lejeune Pascale,Rouffiac Valérie,Elie Nicolas,Bribes Estelle,Demers Brigitte,Vrignaud Patricia,Bissery Marie-Christine,Brulé Aude,Koscielny Serge,Péronneau Pierre,Lassau Nathalie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference45 articles.

1. Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development

2. Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques

3. Imaging Angiogenesis: Applications and Potential for Drug Development

4. Molecular Imaging of Antiangiogenic Agents

5. Evaluation of Contrast-Enhanced Color Doppler Ultrasound for the Quantification of Angiogenesis In Vivo

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of early response to chemotherapy for non-Hodgkin’s lymphoma by quantitative contrast-enhanced ultrasound: A prospective case-control crossectional study;European Journal of Radiology;2024-07

2. Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors;International Journal of Gynecologic Cancer;2023-11-20

3. Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma;Oncology;2022-12-14

4. Microbubble-Assisted Ultrasound for Imaging and Therapy of Melanoma Skin Cancer: A Systematic Review;Ultrasound in Medicine & Biology;2022-11

5. Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound;Cancer Reports;2021-06-09